For: | Zhou SL, Wang LD. Circulating microRNAs: Novel biomarkers for esophageal cancer. World J Gastroenterol 2010; 16(19): 2348-2354 [PMID: 20480519 DOI: 10.3748/wjg.v16.i19.2348] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i19/2348.htm |
Number | Citing Articles |
1 |
Somayeh Salehi, Amir Hossein Jafarian, Mohammad Mahdi Forghanifard. Expression analysis of BRUCE protein in esophageal squamous cell carcinoma. Annals of Diagnostic Pathology 2016; 24: 47 doi: 10.1016/j.anndiagpath.2016.07.003
|
2 |
Ka Wan Emily Cheung, Sin-yu Rachel Choi, Lok Ting Claire Lee, Nga Lam Ella Lee, Hin Fung Tsang, Yin Tung Cheng, William Chi Shing Cho, Elaine Yue Ling Wong, Sze Chuen Cesar Wong. The potential of circulating cell free RNA as a biomarker in cancer. Expert Review of Molecular Diagnostics 2019; 19(7): 579 doi: 10.1080/14737159.2019.1633307
|
3 |
Kewal K. Jain. Applications of Biotechnology in Oncology. 2014; : 87 doi: 10.1007/978-1-4614-9245-0_5
|
4 |
Joseph J. Nalluri, Debmalya Barh, Vasco Azevedo, Preetam Ghosh. miRsig: a consensus-based network inference methodology to identify pan-cancer miRNA-miRNA interaction signatures. Scientific Reports 2017; 7(1) doi: 10.1038/srep39684
|
5 |
Debmalya Barh, Vaishali Agte, Dipali Dhawan, Varsha Agte, Harish Padh. Molecular and Cellular Therapeutics. 2012; : 18 doi: 10.1002/9781119967309.ch2
|
6 |
Rodney E. Shackelford, Maisoun Qassim Abdelbaqi, Khaldoon Almhanna, Kenneth Meredith, Domenico Coppola. Molecular Pathology and Diagnostics of Cancer. 2014; : 177 doi: 10.1007/978-94-007-7192-5_6
|
7 |
Danyella Barbosa Dogini, Vinícius D'Avila Bittencourt Pascoal, Simoni Helena Avansini, André Schwambach Vieira, Tiago Campos Pereira, Iscia Lopes-Cendes. The new world of RNAs. Genetics and Molecular Biology 2014; 37(1 suppl 1): 285 doi: 10.1590/S1415-47572014000200014
|
8 |
Abdullah M Alhadheq, Rana Alhadheq, Saad Alkahtani. Aberrant expression of miR-143/miR-223/miR4478 and miR145 as prognostic factor for colorectal cancer patients. Journal of King Saud University - Science 2024; 36(11): 103494 doi: 10.1016/j.jksus.2024.103494
|
9 |
HIROSHI KONO, MASAFUMI NAKAMURA, TAKAO OHTSUKA, YOSUKE NAGAYOSHI, YASUHISA MORI, SHUNICHI TAKAHATA, SHINICHI AISHIMA, MASAO TANAKA. High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma. Oncology Reports 2013; 30(1): 17 doi: 10.3892/or.2013.2443
|
10 |
Orsolya Kiss, Anna-Mária Tőkés, Sándor Spisák, Anna Szilágyi, Norbert Lippai, Borbála Székely, A. Marcell Szász, Janina Kulka. Breast- and Salivary Gland-Derived Adenoid Cystic Carcinomas: Potential Post-Transcriptional Divergencies. A Pilot Study Based on miRNA Expression Profiling of Four Cases and Review of the Potential Relevance of the Findings. Pathology & Oncology Research 2015; 21(1): 29 doi: 10.1007/s12253-014-9770-1
|
11 |
Maryam Hemmatzadeh, Hamed Mohammadi, Mohammad Karimi, Mohammad Hossein Musavishenas, Behzad Baradaran. Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer. Biomedicine & Pharmacotherapy 2016; 82: 509 doi: 10.1016/j.biopha.2016.05.009
|
12 |
Jun Zhang, Zhenli Zhu, Yan Liu, Xueyuan Jin, Zhiwei Xu, Qiuyan Yu, Ke Li, William B. Coleman. Diagnostic Value of Multiple Tumor Markers for Patients with Esophageal Carcinoma. PLOS ONE 2015; 10(2): e0116951 doi: 10.1371/journal.pone.0116951
|
13 |
Nai‐Jun Fan, Chun‐Fang Gao, Guang Zhao, Xiu‐Li Wang, Liang Qiao. Serum peptidome patterns for early screening of esophageal squamous cell carcinoma. Biotechnology and Applied Biochemistry 2012; 59(4): 276 doi: 10.1002/bab.1024
|
14 |
Yaw Opoku-Damoah, Assogba G. Assanhou, Mopa A. Sooro, Cynthia A. Baduweh, Chunmeng Sun, Yang Ding. Functional Diagnostic and Therapeutic Nanoconstructs for Efficient Probing of Circulating Tumor Cells. ACS Applied Materials & Interfaces 2018; 10(17): 14231 doi: 10.1021/acsami.7b17896
|
15 |
Rohinton S. Tarapore, Jonathan P. Katz. Molecular Pathology of Neoplastic Gastrointestinal Diseases. Molecular Pathology Library 2013; 7: 53 doi: 10.1007/978-1-4614-6015-2_4
|
16 |
Junichi Yano, Gerald E. Smyth. Nucleic Acid Drugs. Advances in Polymer Science 2011; 249: 1 doi: 10.1007/12_2011_136
|
17 |
Nai-Jun Fan, Chun-Fang Gao, Chang-Song Wang, Guang Zhao, Jing-Jing Lv, Xiu-Li Wang, Guang-Hui Chu, Jian Yin, Dong-Hui Li, Xiao Chen, Xu-Tao Yuan, Nian-Long Meng. Identification of the up-regulation of TP-alpha, collagen alpha-1(VI) chain, and S100A9 in esophageal squamous cell carcinoma by a proteomic method. Journal of Proteomics 2012; 75(13): 3977 doi: 10.1016/j.jprot.2012.05.008
|
18 |
Huaijun Ji, Ming Cao, Kunlun Ren, Ningbo Sun, Wei Wang, Qiang Zhu, Qi Zang, Zhongmin Jiang. Expression and Clinicopathological Significance of Mel-18 and Bmi-1 in Esophageal Squamous Cell Carcinoma. Technology in Cancer Research & Treatment 2017; 16(6): 828 doi: 10.1177/1533034617705055
|
19 |
Wen-Tao Wang, Chang-Qing Guo, Guang-Hui Cui, Song Zhao. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma. World Journal of Gastroenterology 2019; 25(37): 5604-5618 doi: 10.3748/wjg.v25.i37.5604
|
20 |
Sikhumbuzo Mbatha, Rodney Hull, Zodwa Dlamini. Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making. Biomedicines 2022; 10(10): 2359 doi: 10.3390/biomedicines10102359
|
21 |
Zi-Jun Xie, Gang Chen, Xu-Chao Zhang, Dong-Feng Li, Jian Huang, Zi-Jun Li. Saliva Supernatant miR-21: a Novel Potential Biomarker for Esophageal Cancer Detection. Asian Pacific Journal of Cancer Prevention 2012; 13(12): 6145 doi: 10.7314/APJCP.2012.13.12.6145
|
22 |
Mahin Keshavarz, Mohsen Behpour, Hossain-Ali Rafiee-pour. Recent trends in electrochemical microRNA biosensors for early detection of cancer. RSC Adv. 2015; 5(45): 35651 doi: 10.1039/C5RA01726B
|
23 |
Rachel E. Melhado, Derek Alderson, Olga Tucker. The Changing Face of Esophageal Cancer. Cancers 2010; 2(3): 1379 doi: 10.3390/cancers2031379
|
24 |
Mukesh Verma, Debmalya Barh, Vasco Azevedo. Genomics and Clinical Diagnostics. 2019; : 440 doi: 10.1039/9781782628217-00440
|
25 |
Yu Fang, Dianchun Fang, Jianguo Hu. MicroRNA and its roles in esophageal cancer. Medical Science Monitor 2012; 18(3): RA22 doi: 10.12659/MSM.882509
|
26 |
Jian Gu, Xifeng Wu. MicroRNAs in Cancer Translational Research. 2011; : 201 doi: 10.1007/978-94-007-0298-1_9
|
27 |
|
28 |
Er-Hui Cai, Yong-Xin Gao, Zhong-Zhi Wei, Wei-Ying Chen, Ping Yu, Ke Li. Serum miR-21 Expression in Human Esophageal Squamous Cell Carcinomas. Asian Pacific Journal of Cancer Prevention 2012; 13(4): 1563 doi: 10.7314/APJCP.2012.13.4.1563
|
29 |
Jun Zhang, Zhiwei Xv, Xuefeng Wu, Ke Li, Hamid Reza Baradaran. Potential Diagnostic Value of Serum p53 Antibody for Detecting Esophageal Cancer: A Meta-Analysis. PLoS ONE 2012; 7(12): e52896 doi: 10.1371/journal.pone.0052896
|
30 |
Hadiseh Samiei, Bizhan Sadighi-Moghaddam, Saeed Mohammadi, Abdolsamad Gharavi, Sara Abdolmaleki, Ayyoob Khosravi, Parviz Kokhaei, Hadi Bazzazi, Ali Memarian. Dysregulation of helper T lymphocytes in esophageal squamous cell carcinoma (ESCC) patients is highly associated with aberrant production of miR-21. Immunologic Research 2019; 67(2-3): 212 doi: 10.1007/s12026-019-09079-7
|
31 |
Georgios Tzimagiorgis, Evangelia Z. Michailidou, Aristidis Kritis, Anastasios K. Markopoulos, Sofia Kouidou. Recovering circulating extracellular or cell-free RNA from bodily fluids. Cancer Epidemiology 2011; 35(6): 580 doi: 10.1016/j.canep.2011.02.016
|
32 |
Haibo Zhou, Li Yang, Xinhua Xu, Mingqian Lu, Rong Guo, Daojun Li, Qiao Huang, Yang Liu, Glenn Deng, Yalin Xu. miR‑34a inhibits esophageal squamous cell carcinoma progression via regulation of FOXM1. Oncology Letters 2018; doi: 10.3892/ol.2018.9593
|
33 |
Haifeng Dong, Jianping Lei, Lin Ding, Yongqiang Wen, Huangxian Ju, Xueji Zhang. MicroRNA: Function, Detection, and Bioanalysis. Chemical Reviews 2013; 113(8): 6207 doi: 10.1021/cr300362f
|
34 |
Damini Verma, Neha Dubey, Amit K. Yadav, Anoop Saraya, Rinu Sharma, Pratima R. Solanki. Disposable paper-based screen-printed electrochemical immunoplatform for dual detection of esophageal cancer biomarkers in patients' serum samples. Materials Advances 2024; 5(5): 2153 doi: 10.1039/D3MA00438D
|
35 |
Vanessa F. Bonazzi, Mitchell S. Stark, Nicholas K. Hayward. MicroRNA regulation of melanoma progression. Melanoma Research 2012; 22(2): 101 doi: 10.1097/CMR.0b013e32834f6fbb
|
36 |
Hua Zhao, Jie Shen, Qiang Hu, Warren Davis, Leonardo Medico, Dan Wang, Li Yan, Yuqing Guo, Biao Liu, Maochun Qin, Mary Nesline, Qianqian Zhu, Song Yao, Christine B. Ambrosone, Song Liu. Effects of Preanalytic Variables on Circulating MicroRNAs in Whole Blood. Cancer Epidemiology, Biomarkers & Prevention 2014; 23(12): 2643 doi: 10.1158/1055-9965.EPI-14-0550
|
37 |
Geetika Suyal, Rinu Sharma. Molecular Biomarkers for Cancer Diagnosis and Therapy. 2024; : 275 doi: 10.1007/978-981-99-3746-2_14
|